Has Access to Hepatitis C Virus Therapy Changed for Patients with Mental Health or Substance Use Disorders In The Direct-Acting-Antiviral Period?

Direct‐acting antivirals (DAA) for hepatitis C virus (HCV) became available in 2014, but the role of mental health or substance use disorders (MH/SUD) on access to treatment is unknown. The objective of this study was to examine the extent and predictors of HCV treatment in the pre‐DAA and post‐DAA periods in four large, diverse health care settings in the United States. This study showed that the volume of patients treated for HCV has increased, but disparities in access to treatment continue among those with mental health/substance use disorder.

Click here to read the full article!

Categories: Research